AstraZeneca plans to expand its Global innovation centre in Chennai
British-Swedish multinational pharmaceutical firm AstraZeneca is planning to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai. The firm would invest Rs 176 crore in expansion that would target enhancing capabilities in AI, data analytics, and machine learning, supporting the development of next-generation medicines and digital healthcare solutions.
Also Read: AstraZeneca India to sell its 64-acre production facility in Bengaluru